1. Home
  2. PIPR vs XENE Comparison

PIPR vs XENE Comparison

Compare PIPR & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Piper Sandler Companies

PIPR

Piper Sandler Companies

HOLD

Current Price

$79.97

Market Cap

5.8B

Sector

Finance

ML Signal

HOLD

XENE

Xenon Pharmaceuticals Inc.

HOLD

Current Price

$55.88

Market Cap

5.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PIPR
XENE
Founded
1895
1996
Country
United States
Canada
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.8B
5.3B
IPO Year
2003
2014

Fundamental Metrics

Financial Performance
Metric
PIPR
XENE
Price
$79.97
$55.88
Analyst Decision
Buy
Strong Buy
Analyst Count
3
11
Target Price
$91.38
$68.55
AVG Volume (30 Days)
574.6K
791.7K
Earning Date
05-01-2026
05-08-2026
Dividend Yield
2.26%
N/A
EPS Growth
54.49
N/A
EPS
0.92
N/A
Revenue
$1,904,217,000.00
$311,000.00
Revenue This Year
$12.30
N/A
Revenue Next Year
$13.55
$2,496.48
P/E Ratio
$87.52
N/A
Revenue Growth
24.33
N/A
52 Week Low
$72.48
$28.19
52 Week High
$380.26
$62.91

Technical Indicators

Market Signals
Indicator
PIPR
XENE
Relative Strength Index (RSI) 24.55 48.05
Support Level $76.20 $52.92
Resistance Level $93.06 $56.66
Average True Range (ATR) 2.73 1.91
MACD 4.61 -0.29
Stochastic Oscillator 31.59 42.12

Price Performance

Historical Comparison
PIPR
XENE

About PIPR Piper Sandler Companies

Piper Sandler Cos is an investment bank and institutional securities firm, serving the needs of corporations, private equity groups, public entities, non-profit entities and institutional investors in the United States (U.S.) and internationally. The company provides a broad set of products and services, including financial advisory services; equity and debt capital markets products; public finance services; institutional brokerage services; fundamental equity and macro research services; fixed income services; and alternative asset management strategies. It generates maximum revenue from Advisory services followed by Equity financing.

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

Share on Social Networks: